Medline ADMIT KIT Recall Issued for Sterility Concerns

Source: FDA · United States

Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.

Medline Industries, LP is recalling 1090 units of ADMIT KIT (model DYKA1343A) due to potential impact on sterility assurance level from equipment calibration issues.

What this FDA recall tells you, and what most readers miss

This notice was issued by FDA on May 26, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.

Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.

Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.

What Happened

Medline Industries, LP has initiated a voluntary recall of certain convenience kits after identifying calibration issues with sterilization and packaging equipment. All products underwent validated cycles, but the issues may affect the sterility assurance level (SAL).

Which Products Are Affected

The recall covers Medline Convenience Kits: ADMIT KIT, Model Number DYKA1343A. A total of 1090 units are affected, distributed nationwide in the United States and worldwide. Affected lots include: 21CBV232, 21IBB933, 21IBE395, 21JBF397, 22ABE640, 22EBK467, 22KBA245, 22LBR618, 23CBE825, 23EBC552, 23HBP415, 24BBV821, 24DBK171, 24IBD021, 25DBK346, 25FBN781, 25HBG194, and 25LBC732. Each unit has UDI-DI 10193489312966; cases have UDI-DI 40193489312967. The recall number is Z-2105-2026. This is a Class II recall.

What You Should Do

Consumers and healthcare facilities should contact Medline Industries, LP for further instructions regarding the recalled products.

Why This Matters

The calibration issues have the potential to impact the sterility assurance level of the devices, which are distributed across the United States.

Source

FDA Recall Z-2105-2026 - Medline Industries, LP, Northfield, IL

Original source: FDA Official Notice ↗

All FDA Recalls →

Nationwide notices with similar length or severity timing 8

Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.

Frequently Asked Questions

Common questions about this FDA recall.

What is this FDA recall about?
Medline Industries, LP is recalling 1090 units of ADMIT KIT (model DYKA1343A) due to potential impact on sterility assurance level from equipment calibration issues.
Which agency issued this alert?
This alert was issued by FDA. The original notice is available at the source link at the bottom of this article.
How severe is this alert?
This alert is classified as "medium" severity. Stay informed and follow agency guidance.
What area is affected?
This alert affects United States. Check with FDA for the most current geographic scope.
Where can I find more FDA Recalls updates?
Browse the full FDA Recalls feed on Areazine at areazine.com/recalls/fda/ for the latest updates from FDA and other agencies.